BioPharma Dive April 24, 2024
An expanded partnership with OpenAI is helping Moderna embed custom-built AI chatbots in a wide range of research and business processes.
Moderna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday said it has expanded a partnership with OpenAI, the buzzy creator of ChatGPT, to give its thousands of employees access to custom-built AI chatbots.
Moderna hopes these tailored versions of the AI tool that made OpenAI famous will help boost its employees’ productivity as it attempts to bring 15 new vaccine and drug products over the next five years. Already, the biotech says its employees have created and deployed more than 750 “GPTs,” including tools that help its drug researchers select vaccine doses for testing...
Today's Sponsors
Today's Sponsor